Champoux Jennifer

Chief Operating Officer

Champoux Jennifer has filed 6 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Jul 16, 2026.

On the most recent filing, Champoux Jennifer is listed as Chief Operating Officer at Monte Rosa Therapeutics, Inc. Inside the rolling window, Champoux Jennifer reported no open-market purchases and 6 open-market sales totaling $311K in GLUE. The largest disclosed transaction in the window is a sale of 4,351 GLUE shares on Jul 15, 2026, worth $102K.

Companies traded

Other insiders at GLUE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$311K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
GLUESale$102KJul 16SEC ↗
GLUESale$44KJun 25SEC ↗
GLUESale$41KJun 18SEC ↗
GLUESale$44KMay 28SEC ↗
GLUESale$41KMay 26SEC ↗
GLUESale$40KJan 5SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Champoux Jennifer made?

Champoux Jennifer has filed 6 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.

Which companies does Champoux Jennifer trade?

Champoux Jennifer has filed SEC Form 4 disclosures for 1 company, including GLUE.

When was Champoux Jennifer's most recent SEC Form 4 filing?

Champoux Jennifer's most recent SEC Form 4 filing on Tracefour is dated Jul 16, 2026.

What is Champoux Jennifer's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Champoux Jennifer is listed as Chief Operating Officer.

What is Champoux Jennifer's total buy and sell value in the current window?

Inside the rolling retention window, Champoux Jennifer bought $0 and sold $311K based on SEC Form 4 filings.

What was Champoux Jennifer's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 4,351 GLUE shares on 2026-07-15, worth $102K, per SEC Form 4 filings.